Patents Examined by Nabila Ebrahim
-
Patent number: 10016465Abstract: A cured non-polymeric gel including a plurality of non-polymeric cross-links. The non-polymeric cross-links result from curing an oil or oil composition at selected curing conditions to achieve a desired amount of cross-linking to form the non-polymeric get. The desired amount of cross-linking is selected based on a desired rate of degradation of the gel after the gel is implanted. The oil or oil composition comprises one or more of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or alphalinolenic acid (ALA).Type: GrantFiled: October 10, 2014Date of Patent: July 10, 2018Assignee: ATRIUM MEDICAL CORPORATIONInventors: Roger Labrecque, Philip McNamara, Joseph Ferraro, Lisa Rogers, Paul Martakos, Theodore Karwoski, Steve A. Herweck, Keith M. Faucher, Thomas M. Swanick
-
Patent number: 9861120Abstract: Disclosed are infant formulas and corresponding methods of using them to promote retinal health and vision development in infants. The formulas, which are free of egg phospholipids and comprise fat, protein, carbohydrate, vitamins, and minerals, including docosahexaenoic acid and, on a ready-to-feed basis, at least about 50 mcg/liter of lutein, wherein the weight ratio of lutein (mcg) to docosahexaenoic acid (mg) is from about 1:2 to about 10:1. The formulas are also believed to be especially useful in reducing the risk of retinopathy of prematurity in preterm infants.Type: GrantFiled: October 10, 2014Date of Patent: January 9, 2018Assignee: Abbott LaboratoriesInventors: Bridget Barrett-Reis, Pamela T. Price, Amy Mackey
-
Patent number: 9851351Abstract: A therapeutic device to release a therapeutic agent comprises a porous structure coupled to a container comprising a reservoir. The reservoir comprises a volume sized to release therapeutic amounts of the therapeutic agent for an extended time when coupled to the porous structure and implanted in the patient. The porous structure may comprise a first side coupled to the reservoir and a second side to couple to the patient to release the therapeutic agent. A plurality of interconnecting channels can extend from the first side to the second side so as to connect a first a plurality of openings on the first side with a second plurality of openings on the second side.Type: GrantFiled: December 17, 2015Date of Patent: December 26, 2017Assignee: ForSight Vision4, Inc.Inventors: Cary J. Reich, Michael Barrett, Randolph E. Campbell, Kathleen C. Farinas
-
Patent number: 9827271Abstract: Lung volume reduction by isolating a target lung portion from the rest of the lung with a mass of extracellular matrix (“ECM”) material. The procedure can be performed by locating a tube within the lumen of an airway to be obstructed and depositing an amount of flowable or other ECM in the open space until the lumen is occluded. Optionally, the procedure may be performed by delivering a plug substantially comprised of ECM material into the lumen of an airway to be obstructed. Further optionally, the ECM plug may include a one-way valve to allow air and mucous to escape from the isolated lung portion.Type: GrantFiled: March 14, 2014Date of Patent: November 28, 2017Assignee: Cook Biotech IncorporatedInventors: Umesh H. Patel, Bhavin Shah, Michelle Chutka
-
Patent number: 9770538Abstract: Skin regeneration or grafting is promoted utilizing a structure including a multi-layer sheet of collagen membrane material which includes a purified collagen barrier sheet material derived from natural collagen-containing tissue, the barrier sheet material including a barrier layer with an outer smooth barrier face and a fibrous face opposite the smooth barrier face. The structure further includes a matrix layer of collagen sponge material adjacent to the fibrous face. The matrix layer of collagen sponge material is resorbed by a body of a subject at a substantially faster rate than the barrier sheet material.Type: GrantFiled: January 18, 2010Date of Patent: September 26, 2017Assignee: Geistlich Pharma AGInventors: Alan S. Herford, Lothar Schloesser, Peter Geistlich
-
Patent number: 9770419Abstract: The present invention provides a composition, a dairy product, and a method for treating a disorder in a subject. The composition includes (i) polymeric nanoparticles and (ii) camel derived glycosaminoglycans (GAG)s ionic complex encapsulated into the nanoparticles, at least one active ingredient encapsulated into the nanoparticles, or combinations thereof. The nanoparticles are lactoferrin nanoparticles including camel derived lactoferrin, casein nanoparticles including camel derived casein, or combinations thereof. The dairy product includes ice cream or frozen yogurt, wherein the ice cream or frozen yogurt includes the composition and is derived from camel milk or other species of milk. The method for treating a disorder in a subject includes administering a therapeutic dose of the composition to the subject.Type: GrantFiled: July 30, 2013Date of Patent: September 26, 2017Inventors: Shaker A. Mousa, Abdulqader Al Haider, Abdelgalil Abdelgader, Abdullah M. Aldahmash, Abdulkareem Almomen
-
Patent number: 9700344Abstract: Chronic wounds may be treated by debriding necrotic and other devitalized tissue from the wound, and applying to the wound an extracellular polymeric substance solvating system comprising a metal ion sequestering agent, surfactant and buffering agent. The solvating system disrupts biofilms which may be present in the wound and aids or enables the resumption of normal healing.Type: GrantFiled: June 25, 2014Date of Patent: July 11, 2017Assignee: MEDTRONIC XOMED, INC.Inventors: Matthew F. Myntti, Dana A. Oliver, James B. Hissong, Jennifer G. Medina
-
Patent number: 9669001Abstract: A composition for use on skin and wounds, comprising a photo-catalyst which is capable of preferentially staining biofilms the composition being for use in the diagnosis and treatment of biofilms in wounds.Type: GrantFiled: December 18, 2009Date of Patent: June 6, 2017Assignee: CONVATEC TECHNOLOGIES INC.Inventors: Phillip Godfrey Bowler, Daniel Gary Metcalf, David Parsons
-
Patent number: 9635872Abstract: This invention provides edible compositions comprising pharmaceutically or nutraceutically active agents in particulate form homogeneously dispersed in a fat matrix, such as chocolate or chocolate compound coating.Type: GrantFiled: September 15, 2015Date of Patent: May 2, 2017Assignee: Delavau L.L.C.Inventor: Kevin W. Lang
-
Patent number: 9623047Abstract: A composition to moderate excessive and potentially harmful gastric acid levels in the gastrointestinal tract of horses is disclosed. The composition includes calcium oxide and/or calcium hydroxide, which may be in combination with various buffers and other ingredients such as sodium bicarbonate, sodium bentonite, sodium sesquicarbonate, calcium carbonate, magnesium oxide, omega-3 and omega-6 fatty acid sources, simple carbohydrates, and/or probiotics. A method of administering the composition is also disclosed.Type: GrantFiled: December 19, 2013Date of Patent: April 18, 2017Assignee: Photo Finish Supplements, LLCInventor: James E. Sherman
-
Patent number: 9585973Abstract: The invention relates to liquid vehicles that can be used to create dilute solutions of water-soluble pharmaceutical or non-pharmaceutical oral contrast agents. The liquid vehicles are formulated to provide desired osmolalities, viscosities, pH, and taste masking capabilities to match the particular intentions of the user and to complement the inherent differences in the various oral contrast agents. The liquid vehicles comprise an aqueous medium, an osmotic agent to adjust osmolality, a buffering agent, a viscosity agent, and sweeteners and flavoring agents to improve palatability.Type: GrantFiled: February 6, 2014Date of Patent: March 7, 2017Inventor: Peter Quagliano
-
Patent number: 9585836Abstract: The invention relates to liquid vehicles that can be used to create dilute solutions of water-soluble pharmaceutical or non-pharmaceutical oral contrast agents. The liquid vehicles are formulated to provide desired osmolalities, viscosities, pH, and taste masking capabilities to match the particular intentions of the user and to complement the inherent differences in the various oral contrast agents. The liquid vehicles comprise an aqueous medium, an osmotic agent to adjust osmolality, a buffering agent, a viscosity agent, and sweeteners and flavoring agents to improve palatability.Type: GrantFiled: February 7, 2011Date of Patent: March 7, 2017Inventor: Peter Quagliano
-
Patent number: 9579343Abstract: The present invention provides a tablet core which comprises at least about 95% by weight of an aliphatic amine polymer. The invention also provides a method of producing a tablet core comprising at least about 95% by weight of an aliphatic amine polymer resin The method comprises the step of compressing the aliphatic amine polymer to form the tablet core. The tablet core can further include one or more excipients. In this embodiment, the method of producing the tablet core comprises the steps of: (1) hydrating the aliphatic amine polymer to the desired moisture level; (2) blending the aliphatic amine polymer with the excipients in amounts such that the polymer comprises at least about 95% by weight of the resulting blend; and (3) compressing the blend to form the tablet core. The present invention further relates to a coated tablet comprising an aliphatic amine polymer core wherein the coating is a water based coating.Type: GrantFiled: September 9, 2014Date of Patent: February 28, 2017Assignee: GENZYME CORPORATIONInventors: Joseph Tyler, John S. Petersen
-
Patent number: 9533050Abstract: The invention relates to a sustained-release vaginal ring which includes meloxicam and an agent for modulating the release of the active principle, such as polyvinylpyrrolidone K-30, which releases the active principle over at least 90 days and which can be used as a continuous-use contraceptive in women. The vaginal ring preferably includes 5 wt % to 30 wt % of meloxicam, relation to total weight of the formulation.Type: GrantFiled: December 29, 2011Date of Patent: January 3, 2017Assignee: LABORATORIOS ANDROMACO S.A.Inventors: Shu-Chen Chen, Marianela del Carmen Beltran Apablaza
-
Patent number: 9522188Abstract: The present invention relates to a solid pharmaceutical dosage form for abusable drug delivery with reduced illicit abuse potential. The dosage form is presented as a bioerodable transmucosal delivery device that includes an abusable drug and an antagonist to the abusable drug associated with an abuse-resistant matrix. The devices of the invention may be in the form of a layered film or a tablet. Upon application in a non-abusive manner, the device adheres to the mucosal surface, providing transmucosal drug delivery of the drug with minimal absorption of the antagonist into systemic circulation.Type: GrantFiled: December 13, 2006Date of Patent: December 20, 2016Assignee: BioDelivery Sciences International, Inc.Inventors: Andrew Finn, Niraj Vasisht
-
Patent number: 9499499Abstract: The invention relates to new salts of valsartan or crystalline, also partly crystalline and amorphous salts of valsartan, the respective production and usage, and pharmaceutical preparations containing such a salt.Type: GrantFiled: November 15, 2013Date of Patent: November 22, 2016Assignee: Novartis AGInventors: Erwin Marti, Hans Rudolf Oswald, Peter Buehlmayer, Wolfgang Marterer
-
Patent number: 9492492Abstract: Provided are compositions comprising an extract of Lilium martagon and a carrier. Also provided are methods of lightening the skin comprising the step of applying to skin in need of skin lightening treatment an extract of Lilium martagon.Type: GrantFiled: December 17, 2010Date of Patent: November 15, 2016Assignee: Johnson & Johnson Consumer Inc.Inventor: Khalid Mahmood
-
Patent number: 9433583Abstract: A colon vitamin includes ingredients that are delivered to different regions of the digestive tract. A first group of ingredients which can include: vitamin D, folic acid, vitamin B2, vitamin B6, beta-carotene, selenium, curcumin, green tea extract, and a portion of the calcium serving can be in a first delivery mechanism that releases these ingredients in the stomach. A second delivery mechanism is used to deliver elemental calcium intact through the stomach and small intestine to the large intestine. The delivery of the ingredients to specific areas of the digestive tract reduces the risk of colorectal adenomatous polyps and colorectal cancers.Type: GrantFiled: April 23, 2012Date of Patent: September 6, 2016Inventor: Frank J. Farrell
-
Patent number: 9417238Abstract: A therapeutic device to release a therapeutic agent comprises a porous structure coupled to a container comprising a reservoir. The reservoir comprises a volume sized to release therapeutic amounts of the therapeutic agent for an extended time when coupled to the porous structure and implanted in the patient. The porous structure may comprise a first side coupled to the reservoir and a second side to couple to the patient to release the therapeutic agent. A plurality of interconnecting channels can extend from the first side to the second side so as to connect a first a plurality of openings on the first side with a second plurality of openings on the second side.Type: GrantFiled: November 14, 2013Date of Patent: August 16, 2016Assignee: ForSight Vision4, Inc.Inventors: Cary J. Reich, Michael Barrett, Randolph E. Campbell, Kathleen C. Farinas
-
Patent number: 9295269Abstract: The invention relates to a confectionery product comprising an extruded body portion, the body portion having a plurality of capillaries disposed therein, one or more of the capillaries being at least partially filled with a fill material which is a different material from that of the extruded body portion, the fill material and optionally the body portion comprising various active and/or reactive components. Some embodiments are designed to provide sequential release profiles. The invention also relates to a process for the manufacture of the same.Type: GrantFiled: March 23, 2011Date of Patent: March 29, 2016Assignee: READING SCIENTIFIC SERVICES LIMITEDInventors: Peter Clarke, Sarah Marshall